Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
17.68
+1.56 (9.68%)
Nov 22, 2024, 4:00 PM EST - Market closed
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.09 billion as of November 22, 2024. Its market cap has increased by 281.75% in one year.
Market Cap
1.09B
Enterprise Value
1.02B
1-Year Change
281.75%
Ranking
Category
Stock Price
$17.68
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.09B, an increase of 1,975.60%. That is a compound annual growth rate of 42.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.05B | 55.73% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avadel Pharmaceuticals | 1.03B |
| Weave Communications | 1.01B |
| Cogent Biosciences | 1.00B |
| Zymeworks | 995.62M |
| Collegium Pharmaceutical | 966.86M |
| HealthStream | 958.98M |
| Vir Biotechnology | 957.83M |
| AMN Healthcare Services | 945.94M |